
A study evaluated the short-term effects of Multiwavelength Photobiomodulation (PBM) using the LumiThera Valeda Light Delivery System on retinal function in 12 patients (24 eyes) with retinitis pigmentosa (RP). Over nine PBM sessions, improvements were observed in best-corrected visual acuity (BCVA), with mean logMAR values improving significantly from 0.62 to 0.53 (p=0.001). However, changes in visual field parameters such as mean deviation (MD), pattern standard deviation (PSD), and fundal perimeter deviation index (FPDI) were not statistically significant. No adverse effects or abnormalities were detected in structural or functional retinal assessments (OCT, ERG). While PBM shows potential for improving BCVA in RP, larger studies with extended follow-up are needed to confirm its long-term efficacy and safety.
Like
Save
Share